| 1 |
30066934 | Inhibition of cFLIP overcomes acquired resistance to sorafenib via reducing ER stress‑related autophagy in hepatocellular carcinoma. | 2018 Oct |
1 |
| 2 |
28154184 | Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma. | 2017 Apr 21 |
1 |
| 3 |
26662956 | Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway. | 2016 May |
2 |
| 4 |
29431086 | Antitumoral Activity of Sorafenib in Hepatocellular Carcinoma: Effects on Cell Survival and Death Pathways, Cell Metabolism Reprogramming, and Nitrosative and Oxidative Stress. | 2016 |
1 |
| 5 |
25687050 | [Mechanisms of sorafenib induced NB4 cell apoptosis]. | 2015 Feb |
2 |
| 6 |
25738310 | Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2. | 2015 |
1 |
| 7 |
24195809 | A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo. | 2013 Nov 6 |
1 |
| 8 |
22843888 | HDAC inhibitors synergize antiproliferative effect of sorafenib in renal cell carcinoma cells. | 2012 Aug |
1 |
| 9 |
18765530 | Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. | 2008 Sep 1 |
1 |
| 10 |
18787411 | Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. | 2008 Oct |
2 |
| 11 |
17909059 | The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. | 2007 Oct 1 |
2 |